{"rows":[{"id":2238,"title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.","authors":"Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J","journal":"EClinicalMedicine","publication_date":"2020-10-01","publication_year":2020,"doi":"10.1016/j.eclinm.2020.100538","pubmed_id":"33150319","openalex_id":"https://openalex.org/W3087859780","source_url":"https://pubmed.ncbi.nlm.nih.gov/33150319/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Veterans,Safety,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33150319","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33150319/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33150319","source_url":"https://pubmed.ncbi.nlm.nih.gov/33150319/","doi":"10.1016/j.eclinm.2020.100538","pmid":"33150319","publication_date":"2020-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2237,"title":"Psilocybin-assisted group therapy: A new hope for demoralization.","authors":"Hendricks PS","journal":"EClinicalMedicine","publication_date":"2020-10-01","publication_year":2020,"doi":"10.1016/j.eclinm.2020.100557","pubmed_id":"33073220","openalex_id":"https://openalex.org/W3089864945","source_url":"https://pubmed.ncbi.nlm.nih.gov/33073220/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33073220","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33073220/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33073220","source_url":"https://pubmed.ncbi.nlm.nih.gov/33073220/","doi":"10.1016/j.eclinm.2020.100557","pmid":"33073220","publication_date":"2020-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1567,"title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.","authors":"von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX","journal":"EClinicalMedicine","publication_date":"2023-02-01","publication_year":2023,"doi":"10.1016/j.eclinm.2022.101809","pubmed_id":"36636296","openalex_id":"https://openalex.org/W4313530670","source_url":"https://pubmed.ncbi.nlm.nih.gov/36636296/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:36636296","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36636296/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36636296","source_url":"https://pubmed.ncbi.nlm.nih.gov/36636296/","doi":"10.1016/j.eclinm.2022.101809","pmid":"36636296","publication_date":"2023-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1566,"title":"Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.","authors":"von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX","journal":"EClinicalMedicine","publication_date":"2023-02-01","publication_year":2023,"doi":"10.1016/j.eclinm.2023.101841","pubmed_id":"36747965","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36747965/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:36747965","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36747965/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36747965","source_url":"https://pubmed.ncbi.nlm.nih.gov/36747965/","doi":"10.1016/j.eclinm.2023.101841","pmid":"36747965","publication_date":"2023-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":997,"title":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.","authors":"Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R","journal":"EClinicalMedicine","publication_date":"2024-10-01","publication_year":2024,"doi":"10.1016/j.eclinm.2024.102799","pubmed_id":"39764567","openalex_id":"https://openalex.org/W4402747955","source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Contraindications","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39764567","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39764567","source_url":"https://pubmed.ncbi.nlm.nih.gov/39764567/","doi":"10.1016/j.eclinm.2024.102799","pmid":"39764567","publication_date":"2024-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":453,"title":"Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.","authors":"Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS","journal":"EClinicalMedicine","publication_date":"2025-11-01","publication_year":2025,"doi":"10.1016/j.eclinm.2025.103517","pubmed_id":"41048658","openalex_id":"https://openalex.org/W4414476150","source_url":"https://pubmed.ncbi.nlm.nih.gov/41048658/","substance_tags":"psilocybin","topic_tags":"Depression,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41048658","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41048658/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41048658","source_url":"https://pubmed.ncbi.nlm.nih.gov/41048658/","doi":"10.1016/j.eclinm.2025.103517","pmid":"41048658","publication_date":"2025-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":401,"title":"Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.","authors":"Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J","journal":"EClinicalMedicine","publication_date":"2025-12-01","publication_year":2025,"doi":"10.1016/j.eclinm.2025.103692","pubmed_id":"41497513","openalex_id":"https://openalex.org/W4417031290","source_url":"https://pubmed.ncbi.nlm.nih.gov/41497513/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41497513","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41497513/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41497513","source_url":"https://pubmed.ncbi.nlm.nih.gov/41497513/","doi":"10.1016/j.eclinm.2025.103692","pmid":"41497513","publication_date":"2025-12-01","importer_version":"2.1.3","text_redistributed":false}}],"total":7,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"EClinicalMedicine","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}